NCT06155513Terminated
Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema
Impact of a Daily Application of Omega-3 Monoglycerides Based Serum and Cream on Self-assessment of Eczema Severity as Well as on the Ratio of 4 Bacteria of the Skin Microbiota (Staphylococcus Aureus, Staphylococcus Epidermis, Cutibacterium Acnes and Streptococcus Pyogenes): Exploratory Study (COS-PBP-02)
Source: ClinicalTrials.gov · Last updated 22 Apr 2026
Reason given: There has been an important change to the product formulation.
Brief summary (registry, in English)
This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different treatments for forty-two days. The baseline condition will serve as a control for the effects observed after treatment on the targeted eczema area.
- Status (registry)
- Terminated
- Study type
- Interventional
- Enrollment
- 7 (actual)
- First submitted
- 24 Nov 2023
- Start date
- 20 Dec 2023
- Primary completion date
- 5 Nov 2025
- Lead sponsor
- SCF Pharma
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06155513
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Participant aged of at least 18 years old.
- Participant diagnosed with eczema who did not use corticosteroids in the 14 days prior to study day 1;
- Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
- Participant without intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SCF Pharma | Rimouski | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.